Opioid research in the time of the opioid crisis.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 793, doi. 10.1111/bph.16043
- By:
- Publication type:
- Article
Works matching IS 00071188 AND DT 2023 AND VI 180 AND IP 7
Results: 15
1
2
Issue Information.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 791, doi. 10.1111/bph.15875
- Publication type:
- Article
3
Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 843, doi. 10.1111/bph.15792
- By:
- Publication type:
- Article
4
Increased heroin intake and relapse vulnerability in intermittent relative to continuous self‐administration: Sex differences in rats.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 910, doi. 10.1111/bph.15791
- By:
- Publication type:
- Article
5
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 994, doi. 10.1111/bph.15772
- By:
- Publication type:
- Article
6
Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 894, doi. 10.1111/bph.15771
- By:
- Publication type:
- Article
7
Metabolic interactions of benzodiazepines with oxycodone ex vivo and toxicity depending on usage patterns in an animal model.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 829, doi. 10.1111/bph.15765
- By:
- Publication type:
- Article
8
Strategies towards safer opioid analgesics—A review of old and upcoming targets.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 975, doi. 10.1111/bph.15760
- By:
- Publication type:
- Article
9
Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l‐Dopa‐induced dyskinesia.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 927, doi. 10.1111/bph.15730
- By:
- Publication type:
- Article
10
The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 879, doi. 10.1111/bph.15656
- By:
- Publication type:
- Article
11
Remote local photoactivation of morphine produces analgesia without opioid‐related adverse effects.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 958, doi. 10.1111/bph.15645
- By:
- Publication type:
- Article
12
Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 862, doi. 10.1111/bph.15592
- By:
- Publication type:
- Article
13
Understanding and countering opioid‐induced respiratory depression.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 813, doi. 10.1111/bph.15580
- By:
- Publication type:
- Article
14
The anomalous pharmacology of fentanyl.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 797, doi. 10.1111/bph.15573
- By:
- Publication type:
- Article
15
A novel G protein‐biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein‐coupled receptor kinase.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 7, p. 943, doi. 10.1111/bph.15334
- By:
- Publication type:
- Article